Anchyra Partners
ABBV icon

Anchyra Partners’s AbbVie ABBV Stock Holding History

Anchyra Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.76M Buy
6,728
+1,342
+25% +$344K 0.37% 51
2026
Q2 		$1.36M Sell
5,386
-13
-0.2% -$2.8K 0.33% 61
2026
Q1 		$1.17M Buy
5,399
+343
+7% +$76.1K 0.36% 53
2025
Q4 		$1.16M Buy
+5,056
New +$1.15M 0.35% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Anchyra Partners's ABBV Position: Q3 2026 in Review

Anchyra Partners increased its AbbVie (ABBV) stake by 25% in Q3 2026, buying an estimated $344K and bringing the position to 6,728 shares worth $1.76M. The position accounts for 0.37% of the portfolio, ranked #51.

Anchyra Partners first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Anchyra Partners held 6,728 shares of AbbVie worth $1.76M as of Q3 2026.
  • Anchyra Partners bought 1,342 AbbVie shares in Q3 2026, an estimated $344K.
  • AbbVie made up 0.37% of Anchyra Partners's portfolio in Q3 2026, its #51 holding.
  • Anchyra Partners first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.